Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.040
+0.110 (3.75%)
At close: Apr 28, 2026, 4:00 PM EDT
2.980
-0.060 (-1.97%)
After-hours: Apr 28, 2026, 7:27 PM EDT
Cyclerion Therapeutics Employees
Cyclerion Therapeutics had 1 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$2,074,000
Profits / Employee
-$3,528,000
Market Cap
12.85M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Lunai Bioworks | 29 |
| BioCardia | 21 |
| Moleculin Biotech | 17 |
| BioVie | 13 |
| Intensity Therapeutics | 7 |
| Traws Pharma | 7 |
| Phio Pharmaceuticals | 6 |
| Jupiter Neurosciences | 5 |
CYCN News
- 27 days ago - Cyclerion Therapeutics Stock Soars 350% On Korsana Merger, $380 Million Financing - Benzinga
- 27 days ago - Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement - Business Wire
- 2 months ago - Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board - GlobeNewsWire
- 4 months ago - Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression - GlobeNewsWire
- 7 months ago - Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company - GlobeNewsWire
- 1 year ago - Cyclerion's sGC Stimulator Portfolio Generates Revenues to Enable Company Growth - GlobeNewsWire
- 1 year ago - Regina Graul, Ph.D., Promoted to Chief Executive Officer - GlobeNewsWire
- 2 years ago - Cyclerion Appoints Regina Graul, Ph.D., as President - GlobeNewsWire